2515. Evaluation of the Equivalency of the Oxoid Sulbactam-Durlobactam (10/10µg) Antimicrobial Disc to the CLSI M07 Broth Microdilution Frozen Reference Method

BACKGROUND: Sulbactam-durlobactam is an intravenous (IV) investigational drug that is a combination of an IV β-lactam antibiotic (sulbactam), and a novel broad-spectrum IV β-lactamase inhibitor (durlobactam). Sulbactam-durlobactam (SUD) is being developed for the treatment of serious infections caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajek, Katie L, Lovatt, Amie J, Bhalerao, Shilpa, Khan, Nagina, Staats, Dylan T, Hendrix, Megan M, Holliday, Nicole M, Knapp, Cindy C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677405/
http://dx.doi.org/10.1093/ofid/ofad500.2133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677405/
http://dx.doi.org/10.1093/ofid/ofad500.2133

Ejemplares similares